Loading your page…

Pharmaceutical group

Omrix

15 medicines4 countries

A group of 4 companies with 15 medicines in 4 countries.

Its medicines

Group structure

4 companies in 2 countries

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

15 medicines

Medicine	Substance	Country	Status	Authorised
EVICEL SOLUCIONES PARA ADHESIVO TISULAR50-90 mg/ml + 800-1,200 UI/ml · Solución para adhesivo tisular	Human fibrinogen, Human thrombin	Spain	Authorised	2016
Evithrom20ml iu/ml · Solution	Thrombin, topical	United States	Not marketed	2007
Evithrom2ml iu/ml · Solution	Thrombin, topical	United States	Not marketed	2007
Evithrom5ml iu/ml · Solution	Thrombin, topical	United States	Not marketed	2007
Evithrom1600-2400iu/ml · For Injection	Thrombin, topical	United States	Marketed	2009
QUIXIL6.2 mg / ml + 60.0 mg / ml + 1200 unit / ml · Kit, Solution	Calcium chloride, Human fibrinogen, Thrombin	Canada	Authorised
Crosseal, Evicel1ML · Spray	Fibrin sealant	United States	Withdrawn	2003
Crosseal, Evicel2ML · Spray	Fibrin sealant	United States	Withdrawn	2003
Crosseal, Evicel5ML · Spray	Fibrin sealant	United States	Withdrawn	2003
Evarrest	Human fibrinogen, Human thrombin	EU (EMA)	Withdrawn	2013
EVARREST MATRIZ ADHESIVA8,6 mg + 37,5 UI · Matriz adhesiva	Human fibrinogen, Human thrombin	Spain	Withdrawn	2013
Evicel	Human fibrinogen, Human thrombin	EU (EMA)	Withdrawn	2008
EVICEL90 mg / ml + 1200 unit / ml · Kit, Solution	Human fibrinogen, Thrombin	Canada	Cancelled	2011
EVICEL SOLUCIONES PARA ADHESIVO TISULAR140 mg + 2000 UI · Solución para adhesivo tisular	Proteina plasmatica humana, Human thrombin	Spain	Suspended	2009
EVICEL SOLUCIONES PARA ADHESIVO TISULAR3,5 mg + 5000 UI · Solución para adhesivo tisular	Proteina plasmatica humana, Human thrombin	Spain	Suspended	2009

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
United States	7	4	3	Companies All medicines
Spain	4	1	3	Companies All medicines
Canada	2	1	1	Companies All medicines
European Union (EMA)	2	0	2	Companies All medicines

Also in the registers of Brazil, France

Sources and licences

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Anvisa, Brazil

Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.

Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions

Health Canada, Canada

Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

All 10 sources

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

U.S. Food and Drug Administration

FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.

Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions

Report an error or request removalCorrections from the company itself are welcome.

Omrix

Group structure

Belgium1

Spain1

Headquarters not stated2

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Other big groups

Group structure

🇧🇪Belgium1

🇪🇸Spain1

Headquarters not stated2

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Belgium1

Spain1